Old Web
English
Sign In
Acemap
>
authorDetail
>
Hjalmar Flygt
Hjalmar Flygt
Uppsala University Hospital
Clinical trial
Adverse effect
Internal medicine
Medicine
chronic myeloid leukaemia
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.
2021
European Journal of Haematology
Hjalmar Flygt
Stina Söderlund
Jesper Stentoft
Johan Richter
Perttu Koskenvesa
Satu Mustjoki
Waleed Majeed
Anna Lübking
Arta Dreimane
Berit Markevärn
Leif Stenke
Kristina Myhr-Eriksson
Bjørn Tore Gjertsen
Tobias Gedde-Dahl
Andreja Dimitrijevic
Lene Udby
Ulla Olsson-Strömberg
Henrik Hjorth-Hansen
Show All
Source
Cite
Save
Citations (1)
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
2021
British Journal of Haematology
Hjalmar Flygt
Fredrik Sandin
Torsten Dahlén
Arta Dremaine
Anna Lübking
Berit Markevärn
Kristina Myhr-Eriksson
Karin Olsson
Ulla Olsson-Strömberg
Anders Själander
Stina Söderlund
Lovisa Wennström
Hans Wadenvik
Leif Stenke
Martin Höglund
Johan Richter
Show All
Source
Cite
Save
Citations (1)
1